Reply has launched an accelerator, Breed Reply, which aims to invest in the most innovative internet of things companies across Europe and the US.

IP Group and angel investors are investing in the Oxford spin-out.

Founders of the angel network already set up Cambridge Capital Group.

The venture capital fund formed and still funded by SAP has renamed itself to reflect its independent status.

Rigontec, which develops RNA-based immunotherapeutics for the treatment of cancer, has raised $11.9m in a series A round featuring High-Tech Gruenderfonds.

Biotherapeutics company Bicycle Therapeutics has raised $32m in a series B round featuring pharmaceutical companies GlaxoSmithKline, Novartis and Astellas.

Edinburgh spin-out pureLifi is about to start selling its next-generation product.

Manchester University spin-out has been seeing its revenue fall this year.

Mobile payment service Inventorum is set to further develop its product with $5.1m in series A funding provided by investors including High-Tech Gruenderfonds.

Andy Tupholme hs joined investment firm Greencoat Capital, where he will work with the firm's $200m ESB Novusmodus fund, which is backed by utility ESB.